Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PKC beta Antikörper (pSer661)

Der Kaninchen Polyklonal anti-PKC beta Antikörper (ABIN7138675) detektiert spezifisch PKC beta in WB und ELISA. Dieser Antikörper reagiert spezifisch mit Proben aus Human.
Produktnummer ABIN7138675
-15% Promotion 2026
336,60 €
396,00 €
Sparen Sie 59,40 € (-15 %)
Zzgl. Versandkosten 20,00 € und MwSt
100 μL
Lieferung nach: Deutschland
Lieferung in 11 bis 15 Werktagen

Kurzübersicht für PKC beta Antikörper (pSer661) (ABIN7138675)

Target

Alle PKC beta (PRKCB) Antikörper anzeigen
PKC beta (PRKCB) (Protein Kinase C, beta (PRKCB))

Reaktivität

  • 131
  • 104
  • 89
  • 13
  • 7
  • 6
  • 5
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 137
  • 4
  • 3
  • 2
  • 1
Kaninchen

Klonalität

  • 122
  • 25
Polyklonal

Konjugat

  • 64
  • 13
  • 8
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Dieser PKC beta Antikörper ist unkonjugiert

Applikation

  • 121
  • 57
  • 54
  • 42
  • 27
  • 26
  • 24
  • 19
  • 18
  • 15
  • 7
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA
  • Bindungsspezifität

    • 16
    • 16
    • 13
    • 11
    • 8
    • 8
    • 8
    • 7
    • 6
    • 5
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer661

    Verwendungszweck

    Phospho-PRKCB (Ser661) Antibody

    Kreuzreaktivität

    Maus, Ratte

    Aufreinigung

    Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi

    Immunogen

    Peptide sequence around phosphorylation site of serine 661 (G-F-S(p)-Y-T) derived from Human PKCB.

    Isotyp

    IgG
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    PKC beta (PRKCB) (Protein Kinase C, beta (PRKCB))

    Andere Bezeichnung

    PRKCB

    Hintergrund

    Background:

    Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase involved in various cellular processes such as regulation of the B-cell receptor (BCR) signalosome, oxidative stress-induced apoptosis, androgen receptor-dependent transcription regulation, insulin signaling and endothelial cells proliferation. Plays a key role in B-cell activation by regulating BCR-induced NF-kappa-B activation. Phosphorylation induces CARD11/CARMA1 association with lipid rafts and recruitment of the BCL10-MALT1 complex as well as MAP3K7/TAK1, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1.

    Zhu M, Chen J, Jiang H, Miao C (2013) Cardiovasc Diabetol 12, 13
    Leonard TA, et al. (2011) Cell 144, 55-66
    Qiao M, et al. (2010) Mol Cell 38, 512-23

    Aliases: KPCB_HUMAN antibody, PKC Beta antibody, PKC-B antibody, PKC-beta antibody, PKCB antibody, Prkcb antibody, PRKCB II antibody, PRKCB2 antibody, Protein kinase C beta antibody, Protein kinase C beta type antibody

    UniProt

    P05771

    Pathways

    WNT Signalweg, T-Zell Rezeptor Signalweg, Thyroid Hormone Synthesis, Nuclear Hormone Receptor Binding, Chromatin Binding, Myometrial Relaxation and Contraction, VEGF Signaling, Unfolded Protein Response, BCR Signaling
Sie sind hier:
Chat with us!